Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19.
Alape-Girón A, Moreira-Soto A, Arguedas M, Brenes H, Buján W, Corrales-Aguilar E, Díaz C, Echeverri A, Flores-Díaz M, Gómez A, Hernández A, Herrera M, León G, Macaya R, Molina-Mora JA, Mora J, Narayanan A, Sanabria A, Sánchez A, Sánchez L, Segura Á, Segura E, Solano D, Soto C, Stynoski JL, Vargas M, Villalta M, Drexler JF, Gutiérrez JM.
Alape-Girón A, et al. Among authors: sanchez l, sanchez a.
Front Med (Lausanne). 2021 Sep 6;8:743325. doi: 10.3389/fmed.2021.743325. eCollection 2021.
Front Med (Lausanne). 2021.
PMID: 34552950
Free PMC article.
No abstract available.